Alpha Tau Medical (DRTS) Free Cash Flow (2021 - 2022)
Alpha Tau Medical's (DRTS) quarterly Free Cash Flow came in at -$8.4 million in Q2 2022, down 33.07% quarter-over-quarter from -$6.3 million in Q1 2022.
Alpha Tau Medical (DRTS) Free Cash Flow (2021 - 2022) Analysis & Trends
Alpha Tau Medical has disclosed Free Cash Flow across 2 years of filings, most recently posting -$8.4 million for Q2 2022.
- Free Cash Flow for Q2 2022 came in at -$8.4 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2023 was -$8.4 million (down 33.07% YoY), and the FY2025 annual result was -$32.8 million, down 48.75% from the prior year.
- Free Cash Flow came in at -$8.4 million for Q2 2022 at Alpha Tau Medical, down from -$6.3 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$2.5 million in Q1 2021 to a low of -$8.4 million in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 63,220.27 |
| 10 | Alpha Tau Medical | 2,384.20 | -76.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -8.37 Mn |
| Jun 30, 2022 | -8.37 Mn |
| Mar 31, 2022 | -6.29 Mn |
| Mar 31, 2022 | -6.29 Mn |
| Mar 31, 2021 | -2.52 Mn |
| Mar 31, 2021 | -2.52 Mn |